(S (NP (ADJP (NN Computer) (HYPH -) (VBN Aided)) (NML (NNP Drug) (NNP Discovery)) (NN research)) (VP (VBZ has) (VP (VBN proven) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ promising) (NN direction)) (PP (IN in) (NP (NN drug) (NN discovery))))))))) (. .))
(S (PP (IN In) (NP (JJ recent) (NNS years))) (, ,) (NP (JJ Deep) (NN Learning) (NNS approaches)) (VP (VP (VBP have) (VP (VBN been) (VP (VBN applied) (PP (IN to) (NP (NP (NNS problems)) (PP (IN in) (NP (NP (DT the) (NN domain)) (PP (JJ such) (IN as) (NP (NNP Drug) (HYPH -) (NNP Target) (NNP Interaction) (NNP Prediction)))))))))) (CC and) (VP (VBP have) (VP (VBN shown) (NP (NP (NNS improvements)) (PP (IN over) (NP (JJ traditional) (NN screening) (NNS methods))))))) (. .))
(S (NP (DT An) (VBG existing) (NN challenge)) (VP (VBZ is) (SBAR (WHADVP (WRB how)) (S (VP (TO to) (VP (VB represent) (NP (NP (NML (NN compound) (HYPH -) (NN target)) (NNS pairs)) (PP (IN in) (NP (NML (JJ deep) (NN learning)) (NNS models))))))))) (. .))
(S (SBAR (IN While) (S (NP (JJ several) (NN representation) (NNS methods)) (VP (VBP exist)))) (, ,) (NP (JJ such) (NN descriptor) (NNS schemes)) (VP (VBP tend) (S (VP (TO to) (VP (VB complement) (NP (CD one) (DT another)) (PP (IN in) (NP (JJ many) (NNS instances))) (, ,) (SBAR (IN as) (S (VP (VBN reported) (PP (IN in) (NP (DT the) (NN literature)))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ multi-view) (NN architecture)) (VP (VBN trained) (ADVP (RB adversarially)) (PP (IN to) (NP (NP (NN leverage)) (NP (DT this) (JJ complementary) (NN behavior)))) (PP (IN by) (S (VP (VBG integrating) (NP (ADJP (DT both) (JJ differentiable) (CC and) (JJ predefined)) (JJ molecular) (NNS descriptors)))))))) (. .))
(S (NP (PRP We)) (VP (VBP conduct) (NP (NP (NNS experiments)) (PP (IN on) (NP (ADJP (RB clinically) (JJ relevant)) (NN benchmark) (NNS datasets)))) (S (VP (TO to) (VP (VB demonstrate) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (PRP$ our) (NN approach)))))))) (. .))
